Rhythm Pharmaceuticals Inc - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

A $180-a-share bet: Can Danaher Corporation turn Masimo into a diagnostics growth engine?

Beyond electronics: Why Flex Ltd.’s EP² deal could reshape critical power supply chains

Why ESR1 mutation targeting is critical in metastatic breast cancer treatment

Is setmelanotide the first true disease-targeted therapy for hypothalamic obesity?

Read More

Pharma Industry News

Is setmelanotide the first true disease-targeted therapy for hypothalamic obesity?

Is setmelanotide redefining hypothalamic obesity treatment? Explore what Rhythm Pharmaceuticals, Inc.’s EU approval means for markets and growth.

bySoujanya Ravi

May 4, 2026

web analytics